Question 1

What are the specific risks associated with the procedures involved in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder clinical trial (NCT06414889). Contact the study team or your healthcare provider for specific answers.

Question 2

How does participating in this trial compare to other treatment options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder clinical trial (NCT06414889). Contact the study team or your healthcare provider for specific answers.

Question 3

What kind of monitoring will I receive during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder clinical trial (NCT06414889). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my platelet count and overall health be assessed before and during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder clinical trial (NCT06414889). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder clinical trial (NCT06414889). Contact the study team or your healthcare provider for specific answers.

Question 6

How often will I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder clinical trial (NCT06414889). Contact the study team or your healthcare provider for specific answers.

What this study is about